Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...

A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month ...

Mark Giaquinto was diagnosed with Parkinson's disease five years ago and continues to combat the illness with a positive ...

Patients living with Parkinson’s disease are encouraged to engage in regular exercise to help manage symptoms and improve ...

At Rock Steady Boxing West Michigan, patients are using boxing as a form of therapy to combat the effects of Parkinson's.

Sleep problems are very common in people with Parkinson’s disease and are associated with poorer quality of life in patients, according to a new Irish study.

Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, and will now pause its development.

The FDA approved a monthly maintenance dosing of intravenous lecanemab (Leqembi) for early Alzheimer's disease, said ...

Researchers have discovered how a cell surface protein called Aplp1 can play a role in spreading material responsible for ...

In the end, I have to be my best advocate for my own care. It took years, but when I became my best advocate, serious change happened,” Choi says.

In a significant advancement for Parkinson’s Disease (PD) therapy, researchers have developed a targeted nano formulation ...